IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

CHI Advisors LLC

Q2 2021 Holdings

Filed 2021-08-11 | 18 holdings | $60.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cullinan Oncology Inc(CGEM)COM230031106$57.8M2,242,84196.2%
Corvus Pharmaceuticals Inc(CRVS)COM221015100$1.9M719,1323.2%
Repare Therapeutics Inc(RPTX)COM760273102$79.2K2,539,6440.1%
Prometheus Biosciences IncCOM74349U108$70.0K2,852,0090.1%
Pliant Therapeutics Inc(PLRX)COM729139105$69.0K2,367,8880.1%
Vectivbio Hldg AGORD SHSH9060V101$30.2K2,585,9860.1%
Oncorus IncCOM68236R103$24.0K1,735,9790.0%
Orchard Therapeutics PLCADS68570P101$17.9K4,081,9720.0%
Inozyme Pharma IncCOM45790W108$15.8K927,2640.0%
Larimar Therapeutics Inc(LRMR)COM517125100$14.9K1,515,1480.0%
Ikena Oncology IncCOM45175G108$11.4K814,7560.0%
Freeline Therapeutics HldgsSPONSORED ADS35655L107$11.2K1,379,8430.0%
Akouos IncCOM00973J101$10.8K858,0270.0%
Precision Biosciences IncCOM74019P108$8.2K651,7290.0%
Keros Therapeutics Inc(KROS)COM492327101$4.9K116,4060.0%
G1 Therapeutics Inc(GTHXEUR)COM3621LQ109$1.1K50,0000.0%
Ovid Therapeutics Inc(OVID)COM690469101$854218,5100.0%
Kezar Life Sciences IncCOM49372L100$796146,6800.0%